Poly Medicure

Poly Medicure shares jump 5% on plans to acquire Citieffe Group for ₹324-cr

Poly Medicure shares rose 5 per cent after it announced its decision to fully acquire Italy-based Citieffe Group

Poly Medicure to fully acquire Citieffe Group at value of ₹324 cr

Medical device maker Poly Medicure Ltd on Wednesday said it will fully acquire Italy-based Citieffe Group at an enterprise value of Rs 324 crore (EUR 31 million). The company has signed a definitive agreement to acquire 100 per cent stake in Medistream SA (Group) consisting of Citieffe SRL and its step-down subsidiaries in USA & Mexico, the company said in a statement. Citieffe is an Italy-based manufacturer specialising in the orthopaedic trauma and extremities segment with a direct presence in Italy, USA, and Mexico, and distribution across over 25 countries, it added. This acquisition provides Poly Medicure with an entry point into the large global orthopaedics market, particularly in the trauma and extremities segment, which is the fastest growing and most resilient category within orthopaedics, the company said. "This acquisition marks another step in our journey to become a comprehensive healthcare solutions provider. Citieffe's strong R&D capabilities and diverse trauma

Poly Medicure to acquire Netherlands-based PendraCare for ₹188.5 crore

Poly Medicure has signed agreements to acquire 90 per cent of Netherlands-based PendraCare Group for Rs 188.5 crore, expanding its cardiology business in Europe and the US

Poly Medicure to buy 90% stake in Pendracare Group for ₹188.5 crore

Medical device maker Poly Medicure Ltd on Wednesday said it will acquire 90 per cent stake in the Netherlands-based PendraCare Group from Wellinq Holdings B.V. at an enterprise value of Rs 188.5 crore (18.3 million euros). The company has signed definitive agreements to acquire the stake in PendraCare Group consisting of PendraCare Holdings and Wellinq Medical from Wellinq Holdings BV, Poly Medicure said in a statement. The balance 10 per cent stake will be acquired in 2030 on the basis of actual EBITDA for calendar year 2029, it added. The existing management of PendraCare will continue to lead the business and Sander Hartman, who will continue to hold 10 per cent non-voting shares in the group, will remain as the CEO. PendraCare Group develops, manufactures and sells innovative cardiology catheter solutions and provides design, development and manufacturing services to other global OEMs. "This move brings us a valuable, 'made-in-Europe' cardiology consumables business with FDA a

Poly Medicure to invest ₹500 cr in new plants for global market push

Poly Medicure to set up three plants in Faridabad, Haridwar, and Jaipur for dialysis, cardiology, and oncology devices, targeting US, Europe, and Brazil markets by FY28

Poly Medicure Q4 results: Profit rises 34% on strong exports, new divisions

Poly Medicure posted a 34 per cent rise in Q4 net profit to Rs 91.8 crore, with revenue up 16.6 per cent, driven by strong export performance and new business verticals

Medical device company share price zooms 47% in 1 month. Do you own?

Poly Medicure, a leading medical device company with a dominant position in India's medical consumables market, rallied 5 per cent to ₹2,922 on the BSE in Wednesday's intra-day trade.

Poly Medicure to deploy Rs 1,000 cr fundraise for capex, future buys

The company is looking at portfolio expansion and increasing the number of products being added each year

Poly Medicure shares rally after successfully raising Rs 1,000 cr via QIP

Poly Medicure's share price increased up to 2.22 per cent at Rs 2195 per share on the BSE in Friday's intraday deals

Street signs: Gail buyback, Medical device makers to gain, and more

Brokerages are advising their retail clients to buy shares of Gail to take advantage of the arbitrage opportunity.

This Kacholia-owned medical equipment stock has rallied 113% in 3 months

Ace investor Ashish Kacholia held 1.70 million equity shares, or a 1.77 per cent stake, in Poly Medicure at the end of March quarter

Poly Medicure hits fresh high; stock zooms 53% over QIP price

Ace investor Ashish Kacholia held 1.75 million equity shares, or a 1.83 per cent stake, in Poly Medicure as of February 19, 2021

Stocks to watch: Nestle, TCS, Titan, SIS, Poly Medicure, Brookfield REIT

Titan's subsidiary CaratLane Trading has incorporated a wholly-owned subsidiary 'StudioC Inc' and acquired 100 per cent of the total share capital worth $1,50,000

Poly Medicure gains 6% on successful fund raising via QIP issue

The company's QIP committee approved the allotment of 7.63 million equity shares to eligible qualified institutional buyers at a price of Rs 524 per equity share

Poly Medicure extends gain on fixing record date for bonus issue

The stock surged 10% to Rs 633, extending its past two days 9% gain on BSE

Poly Medicure hits 52-week high on bonus issue, interim dividend plan

The stock soared 12% to Rs 449 after the company said that the board will meet on Feb 6, to consider bonus issue.